Ixeris sonchifolia Hance, a normal perennial herb, has effects on appendicitis, headache, menstruation, blood circulation, blood stasis, pain, fibrinolytic enzymes, thrombus formation, coronary artery, myocardial infarct size, PGI2, ET, TXA2, TNF-,αIL-6 and IL-8, etc . However, there was no full coverage about the molecular basis and gene targets of Ixeris sonchifolia injection. PubChem Database and DAVID Database had been used conjunctively to detect the gene IDs, gene targets and their functions. There were 3008 genes found in the final results, 16 kinds of definite functions had been detected, 9 of which had been proved and the effects were focused on the psychological, immune, neurological, metabolic, cardiovascular and cancer functions. Ixeris sonchifolia had a wide effects on various symptoms, which had been reported by previous experiments and verified by this research; however its influences on aging, chemdependency, developmental, normalvariation, reproduction, pharmacogenomic and psychologic functions should be confirmed in the future experiments.
INTRODUCTION
Ixeris sonchifolia Hance, a member of the Compositae Family, is widely distributed in the northeastern place of China, is a small and bitter perennial herb (YAOCHUN et al., 2009) . In China, as a kind of well-known folk medicine, Ixeris sonchifolia has also been used for many years to cure appendicitis, reduce headache, normalize menstruation, invigorate blood circulation and eliminate blood stasis in order to relieve pain (HE et al., 2006; FENG et al., 2001) . More recently, raw extract of Ixeris sonchifolia has been made into an injectable formulation, according to the reports, which has biological activities in several aspects such as inhibition of platelet aggregation, relaxation of vascular smooth muscle, enhancement of cerebral blood flow, improvement of the activities of fibrinolytic enzymes and inhibition of thrombus formation (MAO and JING, 2012) . A clinical observation and an animal study have confirmed that the injection is able to expand coronary artery, increase flow of blood, reduce cardiac load and decrease myocardial infarct size (ZHAOAN and SHOUYUAN, 2005; WANG et al., 2006) . The formulation has also been found in a study to exhibit therapeutic efficiency in restoring stroke patients' neural functions and recovery of daily vasomotor activities (YI et al., 2005) .
Presently, targets related to the mechanism of Ixeris sonchifolia injection, which has been proven by several researches, include prostaglandin I2 (PGI2), endothelin (ET), thromboxane A2 (TXA2), tumor necrosis Factor-α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and protein Bcl-2/Bax (ZHAO-LIANG et al., 2013; LIFANG and MEIJIAN, 2013; WANG et al., 2013) .
However, based on the review of above experiments, there was no full coverage about the molecular basis and gene targets of Ixeris sonchifolia injection. Therefore, particularly it is important to conduct research of Ixeris sonchifolia injection's pharmaceutical effect mechanism, material basis on molecular level and gene targets.
Currently, with the development of Public Databases and Networked Pharmacology Method, according to the information integration among various databases, the interdisciplinary research has become possible, which is able to basically identify the indexes before the experiments, enhance the accuracy and reduce the repeated frequency, and at the same time, the research can be finished on the level of molecular and gene targets (DI et al., 2013) .
So the author had conducted the gene targets of Ixeris sonchifolia Injection based on the method of information integration among various databases in this research, not only to verify the previous experiments but also to give advice to the following designs.
MATERIALS AND METHODS

Data sources
The data sources used were PubChem Database and DAVID Database.
PubChem Database
PubChem (http://pubchem.ncbi.nlm.nih.gov), whose mission is to provide intuitive data analysis tools, and to deliver free and easy access to all deposited data, is a public repository for biological activity data of small molecules and RNAi reagents. The PubChem BioAssay database currently contains 500 000 descriptions of assay protocols, covering 5000 protein targets, 30000 gene targets and providing over 130 million bioactivity outcomes. Bioassay description and data can be searched, reviewed and downloaded on the PubChem information platform by users. And it also enables researchers to collect, compare and analyze biological test results through webbased and programmatic tools (WANG et al., 2009) .
DAVID Database
All tools in the DAVID Bioinformatics Resources (http://david.niaid.nih.gov) aim to provide functional interpretation of large lists of genes derived from genomic studies. DAVID Knowledgebase and five integrated, web-based functional annotation tool suites are consisted in the newly updated DAVID Bioinformatics Resources. The expanded DAVID Knowledgebase now integrates almost all major and well-known public bioinformatics resources centralized by the DAVID Gene Concept, a single-linkage method to agglomerate tens of millions of diverse gene/protein identifiers and annotation terms from a variety of public bioinformatics databases. For any uploaded gene list, the DAVID Resources now provides not only the typical gene-term enrichment analysis, but also new tools and functions that allow users to condense large gene lists into gene functional groups, convert between gene/protein identifiers, visualize many-genesto-many-terms relationships, cluster redundant and heterogeneous terms into groups, search for interesting and related genes or terms, dynamically view genes from their lists on bio-pathways and more. With DAVID, investigators gain more power to interpret the biological mechanisms associated with large gene lists. (SHERMAN et al., 2007) .
Effective Constituents of Ixeris sonchifolia Injection
According to previous experiments, the effective constituents of Ixeris sonchifolia injection basically include chicoric acid; uridine; guanosine; adenosine; 1-caffeoylquinic acid; 3,4-dihydroxy-caftaric acid; 3-caffeoylquinic acid; caffeic anhydride; 11, 13-dihydro-13-prolylixerin Z; 3-p-coumaroylquinic acid; 5-caffeoylquinic acid; 3-feruloylquinic acid; 4-caffeoylquinic acid; caffeic acid; 5-p-coumaroylquinic acid; 1, 3-dicaffeoylquinic acid; 4-feruloylquinic acid; luteolin-7-O-β-D-gentiobioside; sonchifolactone D; luteolin-7-O-β-Dglucuronide; luteolin-7-O-β-D-glucoside; 3,4-dicaffeoylquinic acid; 3, 5-dicaffeoylquinic acid; 11β-hydroxyleucodin-11-O-β-glucopyranoside; apigenin-7-O-β-D-glucuronide; ixerin Z; apigenin-7-O-β-D-glucoside; 4, 5-dicaffeoylquinic acid; 11β-hydroxyleucodin-11-O-β-glucopyranoside isomer; 11β,13-dihydroixerin Z; luteolin; 11, 13-dihydro-13-prolyl-ixerin Z1; acacetin-7-O-β-D-rutinoside (HAO-MING et al., 2013; YING et al., 2013) .
Retrieval Methods
We logged on to PubChem Homepage (http://www.ncbi.nlm.nih.gov/pccompound) and searched for "Uridine". We got the Uridine's CID number (6029) from the site, and we linked back to PubChem homepage and clicked "chemical structure search" below "PubChem Tool". From the display, we clicked on "CID, SMILES, INCHI" below "identity similarity", and input 6029 in the blank, unfold "option" menu. We chose similarity greater than 90 and other options were default. At last, we clicked "search" to enter next level (ZHANG et al., 2013) .
On the basis of PubChem database results, there were 1623 results. On the right side of webpage, we saw the item "BioActivity Experiments" under "Refine your results". Then, we clicked "Bioassays Active (53)", and got 53 main active ingredients. Next, we clicked "BioActivity Analysis" under "Action on your results", and finished target analysis for these 53 active components. The item of "target" was the useful result we needed. We then clicked "download" to download the contents. In the downloaded file, data of "active compounds" showed that results 1-5 were meaningful targets. Found with these meaningful targets was a corresponding "sequence GI used in assays", and these GI number was organized for the next step (ZHANG et al., 2013) . After it, we found out all the corresponding GI number of main components in Ixeris sonchifolia and organized them for the next step.
We logged on to David homepage (http://david.abcc.ncifcrf.gov/summary.jsp) and clicked "upload" under "start analysis". We input all the GI numbers, chose "protein GI Accession" for "step 2", chose "gene list" for "step 3", then started search and observation of results. We clicked "genetic association db disease class", for pop up in another page. Then we could get the Gene ID, Targets and Functions. Finally, we clicked "download file" to completely organize the results. Until now, we totally finished the whole search session and got the aimed results (ZHANG et al., 2013) .
RESULTS
About the effective constituents of Ixeris sonchifolia Injection, there was no record about 3,4-dihydroxy-caftaric acid in David Database. There was no record of caffeic anhydride; 11, 13-dihydro-13-prolyl-ixerin Z; 3-p-coumaroylquinic acid; 4-caffeoylquinic acid; 5-pcoumaroylquinic acid; 4-feruloylquinic acid; luteolin-7-O-β-D-gentiobioside; sonchifolactone D; 11β-hydroxyleucodin-11-O-β-glucopyranoside; ixerin Z; 4, 5-dicaffeoylquinic acid; 11β-hydroxyleucodin-11-O-β-glucopyranoside isomer; 11β, 13-dihydroixerin Z and 11, 13-dihydro-13-prolyl-ixerin Z1 in PubChem Database. Others results of Gene ID, targets and functions of Ixeris sonchifolia injection are shown in Table 1 . results of each ingredient, the frequency of "aging" function, "hematological", "renal", "vision", "chemdependency", "unknown", "infection", "developmental", "normalvariation", "reproduction", "pharmacogenomic", "psych", "immune", "neurological", "metabolic", "other", "cardiovascular", and "cancer" is 49, 59, 65, 80, 99, 101, 104, 108, 138, 140, 178, 208, 251, 252, 257, 276, 282, and 361, respectively. Research conducted by YAOCHUN et al. (2009) suggested that flavonoids, particularly luteolin, in IIxeris sonchifolia contribute to the neuroprotective effects, which made the compounds from these herb reasonable candidates for treatment of cerebral ischemia-reperfusion diseases. In our research, we had found that there were 56 genes in the total 154 genes of "luteolin" having the "Neurological" function, and at the same time, there were 16 genes with the function of "Hematological" improvement.
Ixeris sonchifolia had definite curative effects on ischemic optic neuropathy, which could improve the blood-supply balance and optical microcirculation by changing blood rheological characteristics and hemodynamics with no absolute adverse reaction, so there were greatly significant points on promoting the early recovery and improving the quality of life in patients (HELI, 2013) . In our research, we had found that there were 80 genes in the total 3008 genes having the "Vision" function, and at the same time, there were 59 genes in total with the function of "Hematological" improvement. The effects of genes on "Metabolic" function may be able to accelerate the blood cell's regeneration.
Reports showed that Ixeris sonchifolia Injection could contribute to remove the free radical, restrain the platelet aggregation and enhance the activity of plasmin to protect the ischemia injury (YOUSEF, et al., 2004; JINNA et al., 2006) . In our research, we had found that there were 59 genes in the total 3008 genes having the "Hematological" function, and at the same time, there were 257 genes in total with the function of "Metabolic" improvement, which may offer a reasonable evidence for the previous researches.
In Li et al's research, intravenous drip infusion of Ixeris sonchifolia injection was given to 72 patients with atherosclerosis once daily. Levels of prostaglandin I2 (PGI2), endothelin (ET) and thromboxane A2 (TXA2) were tested from fasting venous blood samples (3 mL) before and after treatment for 1 week.. Compared with the previous levels before treatment, significantly Ixeris sonchifolia injection decreased TXA 2 and ET respectively, but obviously increased PGI2 (P<0.01). So Ixeris sonchifolia injection could improve and adjust the abnormal secretory function of vascular endothelial cells, so vascular endothelial cells could be considered as one of the targets of Ixeris sonchifolia effect (ZHAO-LIANG et al., 2013) . In our research, there were 257 genes with the "Metabolic" function and 282 genes with the "Cardiovascular" function. Especially the genes ID 31881630 and 3915797 had significant effects on prostaglandin G/H synthase and cyclooxygenase.
Interleukin-6 (IL-6) was a kind of acute reactive protein, produced by T lymphocytes, mononuclear macrophages, fibroblasts, endothelial cells and muscle cells, which was named as pro-inflammatory cytokine with tumor necrosis factor and interleukin-1, and it could mediate inflammatory and stress reaction. C-reactive protein (CRP) was the firstly discovered acute response protein in body, which was generally believed as a very sensitive inflammatory tissue damage marker. IL -6 and CRP increased and participated in the occurrence and development of atherosclerosis, playing a very important role. Ixeris sonchifolia injection had protective effect on brain tissue by lowering plasma CRP and IL-6 levels,and could improve the total effective rate (QINGLING, 2011) . In another experiment, it could reduce the IL-8 and TNF-α levels to improve the COPD Assessment Test in COPD patients (LIFANG and MEIJIAN, 2012) . In our research, there were 104 genes with the "Infection" function and 251 genes with the "Immune" function. Especially the genes ID 15724400 and 108936015 had significant effects on IL-4 and IL-8 receptor respectively.
Ixeris sonchifolia could accelerate recovery speed of urinary protein, serum albumin, blood fat, blood coagulation function in primary nephrotic syndrome patients, and had great clinical significance in helping treat the PNS and improve the prognosis of nephrotic syndrome (XIAOJUAN et al., 2013) . In our research, there were 65 genes showing the effects on "Renal" function.
Report showed that the quantity of B16 melanoma living cells and survival rate reduced significantly, the expression level of anti-apoptotic protein Bcl-2 downregulated, the expression level of pro-apoptotic protein Bax upregulated, the quantity of apoptotic bodies and evident karyopyknosis rose and the quantity of mitochondria reduced with dose-dependent manner of IIxeris sonchifolia injection. So IIxeris sonchifolia inhibits malignant melanoma cell growth and enhanced apoptosis cells related to protein Bcl-2/Bax with a linear relationship . In our research, the highest frequency, 361, of "Cancer" function might lay a solid foundation for the above research.
CONCLUSION
Ixeris sonchifolia Hance has effects on appendicitis, headache, menstruation, blood circulation, blood stasis, pain, fibrinolytic enzymes, thrombus formation, coronary artery, myocardial infarct size, PGI2, ET, TXA2, TNF, α-IL-6, and IL-8. In this research, we had detected the gene IDs, gene targets, and their functions about Ixeris sonchifolia Injection based on the method of information integration among various databases. 16 kinds of definite functions had been found, 9 of which had laid a solid foundation for previous reports of Ixeris sonchifolia Injection's effects, and according to the frequency of genes (n > 200), the effects were focused on the psychological, immune, neurological, metabolic, cardiovascular, and cancer functions. At the same time, according to our results, the Ixeris sonchifolia injection may have influences on aging, chemdependency, developmental, normal-variation, reproduction, pharmacogenomic and psychologic functions, which should be verified in the future experiments.
